Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - SEQUENOM INC | d850326dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 12, 2015
SEQUENOM, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-29101 | 77-0365889 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 3595 John Hopkins Court, San Diego, CA | 92121 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code: (858) 202-9000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 | Results of Operations and Financial Condition. |
On January 15, 2015, William Welch, the registrant’s Chief Executive Officer, will present at the JP Morgan 33rd Annual Healthcare Conference in San Francisco, CA, starting at 8:00 am Pacific time to provide an overview of and update on the registrant. The presentation is expected to last approximately 30 minutes and will be webcast live through the “Invest” section of the registrant’s website at www.sequenom.com. An audio replay will be available for 30 days following the initial presentation webcast. The presentation, currently posted on the registrant’s website and attached hereto as Exhibit 99.1 and incorporated herein by reference, provides selected preliminary financial and operational results for the year ended December 31, 2014 and corporate goals for 2015.
The information in this Item 2.02, and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless we expressly set forth in such filing that such information is to be considered “filed” or incorporated by reference therein.
| Item 7.01 | Regulation FD Disclosure. |
The information contained in Item 2.02, Results of Operations and Financial Condition, is incorporated herein by reference in its entirety.
| Item 8.01 | Other Events. |
The information contained in Item 2.02, Results of Operations and Financial Condition, is incorporated herein by reference in its entirety.
Forward-Looking Statements
Statements contained in this Current Report on Form 8-K regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Risks are described more fully in the registrant’s filings with the Securities and Exchange Commission, including without limitation the registrant’s most recent Quarterly Report on Form 10-Q and other documents subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking statements contained in this Current Report on Form 8-K speak only as of the date on which they were made. The registrant undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| 99.1 | Presentation of Sequenom, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SEQUENOM, INC. | ||||||
| Dated: January 12, 2015 | By: | /s/ Jeffrey D. Linton | ||||
| Name: | Jeffrey D. Linton | |||||
| Title: | Senior Vice President, General Counsel | |||||